Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Neogenomics Inc
F:NG9
Neogenomics Inc
F:NG9
Price:
16.745
EUR
0.12%
Market Cap:
€2.1B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
N
|
Neogenomics Inc
F:NG9
|
US |
|
A
|
Argenta Silver Corp
XTSX:AGAG
|
CA |
|
S
|
Swatch Group AG
XMUN:UHR
|
CH |
|
U
|
Unity Software Inc
F:US3
|
US |
|
N
|
Netflix Inc
F:NFC
|
US |
|
F
|
Fastenal Co
XMUN:FAS
|
US |
|
P
|
Phillips 66
XMUN:R66
|
US |
|
N
|
Nippon Yusen KK
XMUN:NYKA
|
JP |
|
C
|
Coinbase Global Inc
F:1QZ
|
US |
|
W
|
Warner Music Group Corp
F:WA4
|
US |
|
Darma Henwa Tbk PT
F:0DH
|
ID |
|
A
|
Air Products and Chemicals Inc
XMUN:AP3
|
US |
|
TechnoPro Holdings Inc
F:30T
|
JP |
|
K
|
Kernel Holding SA
XMUN:0KE
|
UA |
|
Hanjaya Mandala Sampoerna Tbk PT
F:HSZ
|
ID |
|
H
|
Highwood Asset Management Ltd
XTSX:HAM
|
CA |
|
Dyne Therapeutics, Inc
NASDAQ:DYN
|
US |
Wall St Price Targets
NG9 Price Forecast
Based on 12 analysts
Based on 12 analysts
-40% Downside
from
€16.745
today
Neogenomics Inc (NG9)’s 12-month stock price forecast through September 2027 has a consensus target of €10.014, implying 40% downside. The forecast is based on price targets from 12 Wall Street analysts.
NG9 Analyst Rating
No ratings yet
No ratings yet
Neogenomics Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NG9's stock price target?
Price Target
10.014
EUR
10.014
EUR
According to Wall Street analysts, the average 1-year price target for NG9 is 10.014 EUR with a low forecast of 8.351 EUR and a high forecast of 18.99 EUR.
What is the Revenue forecast for Neogenomics Inc?
Projected CAGR
9%
9%
Over the last 13 years, the compound annual growth rate for Revenue has been 21%. The projected CAGR for the next 5 years is 9%.
What is the Gross Profit forecast for Neogenomics Inc?
Projected CAGR
12%
12%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 21%. The projected CAGR for the next 5 years is 12%.